Hay-on-Wye Center of Excellence increases capacity for onsite 2-8°C Cold Chain storage. Philadelphia, USA – December 10, 2018 PCI Pharma Services (PCI), full-servi...

Dive Brief: Bluebird bio can say with more conviction that tweaks made to its LentiGlobin gene therapy are bearing fruit, unveiling Monday updated trial results wi...

The human brain is rich in lipids. Investigators studying Parkinson's disease (PD) have become increasingly interested in lipids since both molecular and genetic stud...

The venom of insects such as wasps and bees is full of compounds that can kill bacteria. Unfortunately, many of these compounds are also toxic for humans, making it i...

A tiny microneedle patch could be the future of delivering therapeutic cell related drugs to the heart of patients after a heart attack. Scientists seeking to impr...

Study published in New England Journal of Medicine (Vienna, 04 December 2018) So-called CAR-T cell therapy is a promising option for treating around a fifth of pa...

Domain Therapeutics’ unique platform technologies will be used to identify novel treatment approaches for neuropsychiatric diseases Domain Therapeutics is eligib...

Philadelphia, USA – December 3, 2018 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commer...

Aspire Blaenau Gwent Shared Apprenticeship Programme Award Winners 2018: PCI’s Macauley Webber (back r...

The European Hematology Association (EHA) and European Society for Blood and Marrow Transplantation (EBMT) will hold the first European CAR T Cell Meeting together in...